Windlas Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22

Sales

432.49

362.15

297.46

252.67

239.72

Operating profit

55.08

43.93

35.83

29.85

27.36

Interest

2.07

1.60

0.52

0.47

0.50

Gross profit

61.89

51.31

41.17

34.86

31.65

EPS (Rs)

16.83

13.94

12.55

10.10

10.82

Other income

8.88

8.97

5.86

5.47

4.80

Stock adjustment

-3.06

-17.94

7.32

-13.99

-2.73

Raw material

269.74

-1.88

6.33

174.84

159.17

Power and fuel

-

-

-

-

-

Employee expenses

68.68

58.82

41.88

34.35

32.25

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

42.05

279.23

206.11

27.62

23.69

Provisions made

-

-

-

-

-

Depreciation

15.05

12.71

6.52

5.66

6.05

Taxation

11.38

9.46

8.56

7.19

2.03

Net profit / loss

35.47

29.14

26.10

22.01

23.57

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.54

10.45

10.40

10.90

10.90

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.74

12.13

12.05

11.81

11.41

GPM (%)

14.02

13.82

13.57

13.50

12.95

NPM (%)

8.04

7.85

8.60

8.53

9.64